New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
07:03 EDTHGSI
theflyonthewall.com: Human Genome and Aegera Therapeutics initiate HGS1029 Trial
Human Genome Sciences and Aegera Therapeutics announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced lymphoid tumors. :theflyonthewall.com



News For HGSI From The Last 14 Days
Check below for free stories on HGSI the last two weeks.
There are 4 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 5, 2010
09:52 EDTHGSI
theflyonthewall.com: Human Genome volume and volatility flat on renewed takeover chatter

Subscribe for More Information :theflyonthewall.com
09:45 EDTHGSI
theflyonthewall.com: Rumor: Human Genome moves higher on renewed takeover speculation

Subscribe for More Information :theflyonthewall.com

February 3, 2010
09:53 EDTHGSI
theflyonthewall.com: Leerink hosts an analyst Biotechnology/Industry conference call

Subscribe for More Information :theflyonthewall.com

January 27, 2010
06:54 EDTHGSI
theflyonthewall.com: Human Genome initiated with an Outperform at RBC Capital

Subscribe for More Information :theflyonthewall.com